Annual report pursuant to Section 13 and 15(d)

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail)

v3.8.0.1
Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Schedule Of Cash Flow Supplemental [Line Items]      
Cash paid for interest $ 99,232 $ 108,101 $ 105,155
Cash paid for income taxes, net of refunds received 95,043 93,368 108,435
Noncash investing and financing activities:      
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment [1] 9,349 (29,471) 2,491
Theatre properties and equipment acquired under capital lease 46,727 33,282 36,544
Investment in NCM - receipt of common units (see Note 5) 18,363 11,111 15,421
Dividends accrued on unvested restricted stock unit awards $ (558) $ (554) (593)
Receipt of promissory note related to sale of investment in a Taiwan joint venture     2,634
Other Affiliates | Taiwan Joint Venture      
Noncash investing and financing activities:      
Receipt of promissory note related to sale of investment in a Taiwan joint venture     $ 2,304
[1] Additions to theatre properties and equipment included in accounts payable as of December 31, 2016 and 2017 were $40,625 and $31,276, respectively.